37 results
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
9 Feb 24
InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer
12:34pm
to the arbitrator for injunctive relief until the arbitration award is rendered or the controversy is otherwise resolved. Before an arbitrator is appointed … or makes a final determination on the merits of the controversy, either Party also may, without waiving any remedy under this Agreement, seek from any
8-K
EX-10.1
INM
InMed Pharmaceuticals Inc
19 Jul 22
InMed Announces Appointment of Chief Operating Officer
7:43pm
apply to the arbitrator for injunctive relief until the arbitration award is rendered or the controversy is otherwise resolved. Before an arbitrator … is appointed or makes a final determination on the merits of the controversy, either Party also may, without waiving any remedy under this Agreement
424B3
t9f azo2c7
6 Jul 22
Prospectus supplement
2:43pm
424B5
x7aao
3 Jun 22
Prospectus supplement for primary offering
9:45pm
424B3
8h9omko 6f
25 Apr 22
Prospectus supplement
5:02pm
424B3
hil8ojopp0y0xhckxx
7 Apr 22
Prospectus supplement
4:46pm
S-3
uh600d6cv97e2 h6
4 Feb 22
Shelf registration
4:36pm
8-K
EX-2.1
rbl14t sg6ea7
13 Oct 21
InMed Pharmaceuticals Completes Acquisition of BayMedica Creating a Market Leader in the Manufacturing of Rare Cannabinoids
5:00pm
10-K
qlrfkdk2046q
24 Sep 21
Annual report
7:31am
10-K
EX-2.1
ikj uegqvu2nobcoer9
24 Sep 21
Annual report
7:31am
424B3
ft2x 4eywte
22 Jul 21
Prospectus supplement
10:27am